Analysis of Aurinia Pharmaceuticals Inc (AUPH)
Aurinia Pharmaceuticals Inc (AUPH) has shown some interesting price movements recently.
Looking at the Relative Strength Index (RSI) indicator, we can see that it has been fluctuating around the mid-range, indicating a balanced market sentiment without any extreme overbought or oversold conditions.
The Moving Average Convergence Divergence (MACD) indicator has been showing some positive values, with the MACD line crossing above the signal line on some days, suggesting potential bullish momentum.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a stable trend without significant divergence.
Overall, based on these indicators, Aurinia Pharmaceuticals Inc seems to be in a consolidation phase with some potential for bullish momentum building up. However, it is essential to consider other factors and conduct a more in-depth analysis before making any trading decisions.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with the highest growth rate expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate is expected to increase further to 9.7% in the next year.
5. Past 5 Years: Over the past 5 years, the company has shown an average annual growth rate of 20.15%.
6. Next 5 Years: Looking ahead, analysts project an average annual growth rate of 9.72% for the next 5 years.
These estimates suggest a positive outlook for the company's growth, with a gradual increase in growth rates expected in the upcoming periods compared to the past performance.
Price target
The analysts' forecast for the future price of the security paper is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price is below both the average and median forecast, indicating that there may be potential for growth according to analysts' expectations.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion and total debt of $104.59 billion, resulting in a current ratio of 1.037. The company has a book value per share of $4.837 and total cash per share of $4.379, with a total debt to equity ratio of 140.968.
In terms of profitability, the company has a profit margin of 26.31% and an operating margin of 30.74%. The return on assets is 22.07% and the return on equity is 147.25%. The most recent quarter ended on March 31, 2024, and the fiscal year ends on September 30, 2023.
From the income statement, we see that the company generated $381.62 billion in revenue, with a gross profit of $169.14 billion and EBITDA of $131.39 billion. The net income to common shareholders is $100.39 billion, resulting in diluted earnings per share of $6.43. The company experienced a quarterly revenue growth of -4.3% and a quarterly earnings growth year-over-year of -2.2%.
Looking at stock statistics, the company has a short ratio of 1.53 and a float of 15.31 billion shares. The shares outstanding are 15.33 billion, with 0.0522% held by insiders and 57.59% held by institutions. The short percent of shares outstanding is 0.65%.
In terms of valuation metrics, the company has a PEG ratio of 26.32, a forward P/E of 26.32, and a trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and a price to sales ratio of 7.65. The enterprise value to EBITDA ratio is 22.76 and the enterprise value to revenue ratio is 7.73. The market capitalization is $2.92 trillion.
The stock price summary shows a beta of 1.264, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The fifty-two-week low is $164.08, the high is $199.62, and the change is 6.85%.
In terms of dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1, resulting in a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%. The dividend date is May 16, 2024, and the ex-dividend date is May 10, 2024. The last split date was August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to the decrease, there was a consistent growth in revenue from FY 2020 to FY 2022.
- FY 2022 had the highest revenue among the four fiscal years analyzed.
These trends in revenue can provide insights into the company's performance and market conditions during these periods.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated but generally increased, with the highest value in 2023 at $143.6 billion.
3. Non-current assets have also shown an increasing trend, reaching $209 billion in 2023.
4. Total liabilities have been increasing steadily, from $248 billion in 2019 to $290.4 billion in 2023.
5. Shareholders' equity has shown some fluctuations but has increased overall, from $90.5 billion in 2018 to $62.1 billion in 2023.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, but there are fluctuations in certain areas that may require further analysis.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows growth compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This indicates an increase from the EPS of $1.35 from the same quarter last year.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. Looking ahead to the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a potential increase from the EPS of $6.10 for the current year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.MACD of AUPH